Literature DB >> 26223475

Increased morbidity and mortality of a concomitant colectomy during a pancreaticoduodenectomy: an NSQIP propensity-score matched analysis.

Jennifer W Harris1, Jeremiah T Martin1, Erin C Maynard1, Patrick C McGrath1, Ching-Wei D Tzeng1.   

Abstract

BACKGROUND: Select patients with peri-ampullary cancers require concomitant colon resection (CR) during a pancreaticoduodenectomy (PD) for margin-negative resections. This study analysed the impact of concomitant CR on major morbidity (MM) and mortality.
METHODS: National Surgical Quality Improvement Program (NSQIP) patients undergoing PD for peri-ampullary cancers were identified from 2005 to 2012. A 4 : 1 propensity-score matched analysis isolated the impact of CR upon PD. Risk factors for 30-day MM and mortality were analysed to determine post-operative sequelae of PD+CR.
RESULTS: From 10 965 PD and 159 PD+CR patients, 624 and 156, respectively, were selected for 4 : 1 matched analysis. PD+CR resulted in a higher MM and mortality (50.0% and 9.0%) versus PD alone (28.8% and 2.9%, respectively, P < 0.001). Multivariate analysis identified risk factors for MM after PD: concomitant CR [odds ratio (OR)-3.19, P < 0.001], smoking (OR-1.92, P = 0.005), a lack of functional independence (OR-3.29, P = 0.018), cardiac disease (OR-2.39, P = 0.011), decreased albumin (per g/dl, OR-1.38, P = 0.033) and a longer operative time (versus median time, OR-1.56, P = 0.029). Independent predictors of mortality included concomitant CR (OR-3.16, P = 0.010), ventilator dependence (OR-13.87, P < 0.001) and septic shock (OR-6.02, P < 0.001).
CONCLUSIONS: CR was an independent predictor of MM and mortality after a PD. Patients requiring PD+CR should be identified pre-operatively, maximally optimized and referred to experienced surgeons at expert centres.
© 2015 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2015        PMID: 26223475      PMCID: PMC4557661          DOI: 10.1111/hpb.12471

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  31 in total

1.  One thousand consecutive pancreaticoduodenectomies.

Authors:  John L Cameron; Taylor S Riall; JoAnn Coleman; Kenneth A Belcher
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

2.  Neoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP).

Authors:  Sung W Cho; Ching-Wei David Tzeng; W Cory Johnston; Maria A Cassera; Philippa H Newell; Chet W Hammill; Ronald F Wolf; Thomas A Aloia; Paul D Hansen
Journal:  HPB (Oxford)       Date:  2013-09-24       Impact factor: 3.647

3.  Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis.

Authors:  Ching-Wei D Tzeng; Thomas A Aloia; Jean-Nicolas Vauthey; George J Chang; Lee M Ellis; Barry W Feig; Steven A Curley; John M Skibber; Eddie K Abdalla; Y Nancy You; Miguel A Rodriguez-Bigas
Journal:  Ann Surg Oncol       Date:  2012-08-30       Impact factor: 5.344

4.  En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?

Authors:  Aaron R Sasson; John P Hoffman; Eric A Ross; Steven A Kagan; James F Pingpank; Burton L Eisenberg
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

5.  Is American College of Surgeons NSQIP organ space infection a surrogate for pancreatic fistula?

Authors:  Janak Atul Parikh; Joal D Beane; E Molly Kilbane; Daniel P Milgrom; Henry A Pitt
Journal:  J Am Coll Surg       Date:  2014-09-03       Impact factor: 6.113

6.  En bloc resection of right-sided colonic adenocarcinoma with adjacent organ invasion.

Authors:  Sorabh Kapoor; Biswabasu Das; Sujoy Pal; Peush Sahni; Tushar K Chattopadhyay
Journal:  Int J Colorectal Dis       Date:  2005-06-07       Impact factor: 2.571

Review 7.  Right hemicolectomy plus pancreaticoduodenectomy vs partial duodenectomy in treatment of locally advanced right colon cancer invading pancreas and/or only duodenum.

Authors:  Roberto Cirocchi; Stefano Partelli; Elisa Castellani; Claudio Renzi; Amilcare Parisi; Giuseppe Noya; Massimo Falconi
Journal:  Surg Oncol       Date:  2014-03-28       Impact factor: 3.279

8.  Covered self-expandable metal stent deployment promises safe neoadjuvant chemoradiation therapy in patients with borderline resectable pancreatic head cancer.

Authors:  Kensuke Kubota; Takamitsu Sato; Seitaro Watanabe; Kunihiro Hosono; Noritoshi Kobayashi; Ryutaro Mori; Koichi Taniguchi; Ryusei Matsuyama; Itaru Endo; Atsushi Nakajima
Journal:  Dig Endosc       Date:  2013-03-31       Impact factor: 7.559

9.  Additional organ resection combined with pancreaticoduodenectomy does not increase postoperative morbidity and mortality.

Authors:  Mehrdad Nikfarjam; Mandeep Sehmbey; Eric T Kimchi; Niraj J Gusani; Serene Shereef; Diego M Avella; Kevin F Staveley-O'Carroll
Journal:  J Gastrointest Surg       Date:  2009-02-07       Impact factor: 3.452

10.  The use of bootstrapping when using propensity-score matching without replacement: a simulation study.

Authors:  Peter C Austin; Dylan S Small
Journal:  Stat Med       Date:  2014-08-04       Impact factor: 2.373

View more
  2 in total

1.  Indication for en bloc pancreatectomy with colectomy: when is it safe?

Authors:  Patrick B Schwartz; Alexandra M Roch; Jane S Han; Alex V Vaicius; William P Lancaster; E Molly Kilbane; Michael G House; Nicholas J Zyromski; C Max Schmidt; Atilla Nakeeb; Eugene P Ceppa
Journal:  Surg Endosc       Date:  2017-06-29       Impact factor: 4.584

2.  The Impact of Increasing Hospital Volume on 90-Day Postoperative Outcomes Following Pancreaticoduodenectomy.

Authors:  Daniel J Kagedan; Nik Goyert; Qing Li; Lawrence Paszat; Alexander Kiss; Craig C Earle; Paul J Karanicolas; Alice C Wei; Nicole Mittmann; Natalie G Coburn
Journal:  J Gastrointest Surg       Date:  2017-01-05       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.